All Stories

  1. Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes
  2. The Relevance of Error Grid Analysis in ISO 15197
  3. Definition, Classification, Diagnostics and Differential Diagnostics of Diabetes Mellitus: Update 2025
  4. Towards Standardization of CGM Performance Studies: The QUSS-CGM Questionnaire for Assessing User Satisfaction
  5. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2025
  6. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  7. Response to Comments on Freckmann et al. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. Diabetes Care 2025;48:1213–1217
  8. Discrepancies between current displayed and auto‐logged glucose values in FreeStyle Libre 3: Implications for clinical interpretation
  9. The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
  10. Comparator Value Pairing Impacts Reported Continuous Glucose Monitoring System Accuracy
  11. Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring Systems
  12. Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM
  13. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems
  14. Compliance With FDA iCGM Special Controls is Dependent on Study Design and Procedures
  15. Calibration and performance of a Raman-based device for non-invasive glucose monitoring in type 2 diabetes
  16. Feasibility of a Glucose Manipulation Procedure for the Standardized Performance Evaluation of Continuous Glucose Monitoring Systems
  17. Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes
  18. Performance of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
  19. The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring
  20. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2024
  21. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  22. Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings
  23. The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors
  24. An SMS-Guided Basal Insulin Titration in People with Type 2 Diabetes New on Insulin
  25. Characteristics of Nocturnal Hypoglycaemic Events and Their Impact on Glycaemia
  26. Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring
  27. Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes
  28. Unlocking Potential: Personalized Lifestyle Therapy for Type 2 Diabetes Through a Predictive Algorithm-Driven Digital Therapeutic
  29. Point-of-care testing: state-of-the art and perspectives
  30. Ein Pilotversuch zu Smartwatches mit Glukosemessfunktion
  31. Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems
  32. Effect of Arterialization on Venous Blood Glucose Concentrations and Implications for Observed Continuous Glucose Monitoring Accuracy
  33. Quality assessment of glucose measurement with regard to epidemiology and clinical management of diabetes mellitus in Germany
  34. Correction: Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
  35. A Critical Discussion of Alert Evaluations in the Context of Continuous Glucose Monitoring System Performance
  36. Benefits of Usability Evaluation in the Development Process of Diabetes Technologies Using the Example of a Continuous Glucose Monitoring System Prototype
  37. A Proposal for the Clinical Characterization of Continuous Glucose Monitoring Trend Arrow Accuracy
  38. Even Head-to-Head Comparison Studies of Continuous Glucose Monitoring System Performance Can be Biased
  39. Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
  40. Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes
  41. Investigation of the Effect of 70 Potential Interferents on Measurement Results of Two Blood Glucose Monitoring Systems
  42. Are You Using the Recommended Test Tubes for Glucose Measurement? New Guidelines for Pre-analytical Handling in Germany
  43. Plasma Glucose Concentrations in Different Sampling Tubes Measured on Different Glucose Analysers
  44. Head-to-Head Evaluation of Continuous Glucose Monitoring and Automated Insulin Delivery Systems: Why are They not Used More Systematically?
  45. Evaluation of System Accuracy, Precision, Hematocrit Influence, and User Performance of Two Blood Glucose Monitoring Systems Based on ISO 15197:2013/EN ISO 15197:2015
  46. Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: A Narrative Review of Challenges and Proposed Solutions
  47. Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial
  48. Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting
  49. Güte der Glukosemessung in niedergelassenen diabetologischen Praxen basierend auf einer Strukturbefragung
  50. Kommentar zu den Konsequenzen aus der „Befragung zur Güte der Glukosemessung in niedergelassenen diabetologischen Praxen basierend auf einer Strukturbefragung“
  51. Comment on Hochfellner et al. Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106
  52. Evaluation of the Tolerability of a Steel Needle and an Adhesive for a Patch Pump
  53. Differences in venous, capillary and interstitial glucose concentrations in individuals without diabetes after glucose load
  54. Glucose measurement and control in patients with type 1 or type 2 diabetes
  55. Automatisierte Insulindosierung: Ideale Diabeteskontrolle mit vielen offenen Fragen
  56. Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy
  57. A Statistical Approach for Assessing the Compliance of Integrated Continuous Glucose Monitoring Systems with Food and Drug Administration Accuracy Requirements
  58. Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
  59. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial
  60. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022
  61. User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Measurement Results
  62. Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems
  63. Improving the Bias of Comparator Methods in Analytical Performance Assessments Through Recalibration
  64. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022
  65. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  66. Suitability of continuous glucose monitoring in healthy subjects to detect effects of meal sequences and nutritional content of meals on postprandial glycemic responses
  67. Real-Time Continuous Glucose Monitoring Can Predict Severe Hypoglycemia in People with Type 1 Diabetes: Combined Analysis of the HypoDE and DIAMOND Trials
  68. Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions
  69. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  70. Accuracy Evaluation of a Novel Reusable Patch Pump Prototype
  71. Patch Pumps: What are the advantages for people with diabetes?
  72. Patch Pumps: Periodic Insulin Delivery Patterns
  73. Definition, Classification and Diagnosis of Diabetes Mellitus
  74. Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus
  75. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  76. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  77. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
  78. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  79. Impact of Blood Glucose Monitoring System Accuracy on Clinical Decision Making for Diabetes Management
  80. Evaluation of the Accuracy and Reliability of a Tubeless Insulin Infusion System Under Laboratory Conditions
  81. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021
  82. Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis
  83. Correction to: Diabetes Technol Ther 2021;23(5):350−357
  84. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021
  85. Response to Seibold: Data Obtained With Early Generations of CGM Sensors: Comment on Pleus et al.
  86. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany
  87. Glukosemessung in der Diabetesdiagnostik und -therapie: Laboratoriumsmedizinische Untersuchung inkl. patientennaher Sofortdiagnostik, Blutglukoseselbstmessung und kontinuierliches Glukosemonitoring
  88. Entwicklung und psychometrische Evaluation eines herstellerunabhängigen Wissenstests zum kontinuierlichen Glukosemonitoring in Echtzeit für insulinbehandelte Menschen mit Diabetes
  89. Development and Psychometric Assessment of a Manufacturer Independent Knowledge Questionnaire on Real Time Continuous Glucose Monitoring for insulin-treated People with Diabetes
  90. Comment on “Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory” by Spanou and Makris
  91. Evaluation of Meal Carbohydrate Counting Errors in Patients with Type 1 Diabetes
  92. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020
  93. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
  94. Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study
  95. Standardization process of continuous glucose monitoring: Traceability and performance
  96. Mean Absolute Relative Difference of Blood Glucose Monitoring Systems and Relationship to ISO 15197
  97. Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation
  98. Diabetesdiagnostik in der Hausarztpraxis
  99. Methoden der Stoffwechselkontrolle – HbA1c versus „time in range“
  100. Variation of Mean Absolute Relative Differences of Continuous Glucose Monitoring Systems Throughout the Day
  101. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  102. Evaluation of Trueness and Precision of a Bench-Top Laboratory Glucose Analyzer Using Reference Materials
  103. Choice of Continuous Glucose Monitoring Systems May Affect Metrics: Clinically Relevant Differences in Times in Ranges
  104. Evaluation of the SPECTRUM training programme for real‐time continuous glucose monitoring: A real‐world multicentre prospective study in 120 adults with type 1 diabetes
  105. Diabetesdiagnostik in der Praxis
  106. Diabetesdiagnostik in der Hausarztpraxis
  107. Diagnostik des Gestationsdiabetes mellitus in der Praxis
  108. Stability of Glucose Concentrations in Frozen Plasma
  109. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control
  110. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020
  111. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  112. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
  113. Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems
  114. Proof of Concept for a New Raman-Based Prototype for Noninvasive Glucose Monitoring
  115. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  116. Der Auftragsverarbeitungsvertrag (AV-Vertrag): Relevanz und praktische Bedeutung für die Diabetologie
  117. Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score
  118. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics
  119. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies
  120. Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management
  121. The YSI 2300 Analyzer Replacement Meeting Report
  122. Measurement accuracy of two professional-use systems for point-of-care testing of blood glucose
  123. Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
  124. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents
  125. Basics and use of continuous glucose monitoring (CGM) in diabetes therapy
  126. System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015
  127. Simple Strategies for Retrospective Detection of Meals in Diabetes Datasets
  128. Comparative Accuracy Analysis of a Real-time and an Intermittent-Scanning Continuous Glucose Monitoring System
  129. Definition, Classification and Diagnosis of Diabetes Mellitus
  130. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  131. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
  132. Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature
  133. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  134. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  135. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia
  136. Concept and Implementation of a Novel Patch Pump for Insulin Delivery
  137. Untersuchung der Messgenauigkeit verschiedener Blutglukosemesssysteme, erworben in Discountern und Drogeriemärkten im Rahmen der Versorgungsforschung in Anlehnung an ISO 15197
  138. Feasibility of Fully Closed Loop Insulin Delivery in Type 2 Diabetes
  139. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  140. Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space
  141. 119-LB: Bolus Dosing Accuracy of Two Recent Insulin Pumps
  142. 279-OR: How to Use rtCGM Data to Predict Future Severe Hypoglycemia?
  143. Advanced carbohydrate counting: An engineering perspective
  144. Deviation Analysis and Interval Modeling as Complementary Tools to Evaluate Insulin Dosing Algorithms in Diabetes
  145. Entwicklung und teststatistische Prüfung eines Wissenstests zum rtCGM (real-time continuous glucose monitoring): „rtCGM-Profi-Check“
  146. Genauigkeit verschiedener Insulinpumpen bei der Abgabe von Basalraten unter Verwendung eines typischen zirkadianen Profils mit zusätzlichen Bolusabgaben
  147. Kontinuierliches Glukosemonitoring bei Menschen ohne Diabetes nach vordefinierten Mahlzeiten und im Alltag
  148. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
  149. Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study
  150. Proof of Concept Study to Assess the Influence of Oxygen Partial Pressure in Capillary Blood on SMBG Measurements
  151. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  152. Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison
  153. The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study
  154. Comment on �accuracy and precision of four main glucometers used in a sub-Saharan African country: a cross-sectional study� by Choukem et al
  155. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
  156. Assessment of System Accuracy, Intermediate Measurement Precision, and Measurement Repeatability of a Blood Glucose Monitoring System Based on ISO 15197
  157. Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
  158. Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices
  159. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
  160. Reporting Insulin Pump Accuracy: Trumpet Curves According to IEC 60601-2-24 and Beyond
  161. Evaluation of Analytical Performance of Three Blood Glucose Monitoring Systems: System Accuracy, Measurement Repeatability, and Intermediate Measurement Precision
  162. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  163. Erratum: Definition, Klassifikation und Diagnostik des Diabetes mellitus
  164. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  165. Correction: Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  166. Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
  167. Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  168. Patch Pumps: Are They All the Same?
  169. Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose MonitoringParts of the data have previously been presented at the 77th Scientific Sessions of the American Diabetes Association in San...
  170. Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring SystemsParts of these data were previously presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes, September 11–15, 2017, Lis...
  171. Accuracy of five systems for self-monitoring of blood glucose in the hands of adult lay-users and professionals applying ISO 15197:2013 accuracy criteria and potential insulin dosing errors
  172. Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps
  173. First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
  174. Definition, Classification and Diagnosis of Diabetes Mellitus
  175. Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany
  176. Definition, classification and diagnostics of diabetes mellitus
  177. Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
  178. Evaluation of Hematocrit Influence on Measurements With a Novel Self-Monitoring of Blood Glucose System Based on ISO 15197:2013
  179. Basal Rate Delivery of Different Insulin Pumps—An Accuracy Evaluation
  180. Delivery of Low Basal Rates in Different Insulin Pumps—An Accuracy Evaluation
  181. Predictors of Hypoglycemia Avoidance in a Randomized Controlled rtCGM Trial (HypoDE)
  182. The Relationship between A1C and Hypoglycemia in the HypoDE Study
  183. Evaluation of Four Blood Glucose Monitoring Systems for Self-Testing with Built-in Insulin Dose Advisor Based on ISO 15197:2013: System Accuracy and Hematocrit Influence
  184. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
  185. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors
  186. HbA1c-Messung in Deutschland: Ist die Qualität ausreichend für Verlaufskontrolle und Diagnose?
  187. Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published
  188. System Accuracy and User Performance Evaluation of an Improved System for Self-Monitoring of Blood Glucose
  189. Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
  190. Identification of Mixed-Meal Effects on Insulin Needs and Glycemic Control
  191. Impact of Carbohydrate Counting Errors on Glycemic Control in Type 1 Diabetes
  192. People with Type 1 Diabetes and Increased Hypoglycemia Frequency have a Higher Risk for Nocturnal Hypoglycemia During the Second Half of the Night
  193. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates
  194. HbA1c-POC-Systeme zur Therapiekontrolle und Diagnostik des Diabetes: Ausreichende Qualität und Qualitätskontrolle?
  195. Flash Glucose Monitoring: Differences Between Intermittently Scanned and Continuously Stored Data
  196. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  197. Praxisempfehlung der DDG: Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  198. Accuracy Evaluation of a New System for Self-Monitoring of Blood Glucose With Three Test Strip Lots Based on ISO 15197:2013
  199. Comparative Handling Analysis of Different Insulin Pump Systems
  200. Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study
  201. ISO 15197: 2013 Evaluation of a Blood Glucose Monitoring System’s Measurement Accuracy
  202. Evaluation of Accuracy of Six Blood Glucose Monitoring Systems and Modeling of Possibly Related Insulin Dosing Errors
  203. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View
  204. Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?
  205. Introduction of a Novel Smartphone-Coupled Blood Glucose Monitoring System
  206. Strengths and Limitations of New Approaches for Graphical Presentation of Blood Glucose Monitoring System Accuracy Data
  207. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in the Hands of Intended Users and Trained Personnel Based on ISO 15197 Requirements
  208. Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block
  209. Accuracy Assessment of an Improved Version of an Established Blood Glucose Monitoring System for Self-Testing Following ISO 15197:2013
  210. Continuous glucose monitoring: A training programme for all age groups
  211. Bolus Calculator Safety Mandates a Need for Standards
  212. Regulatorische Defizite bei Medizinprodukten
  213. Accuracy and user performance evaluation as key factors in self-monitoring in diabetes patients
  214. Significance and Reliability of MARD for the Accuracy of CGM Systems
  215. Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind
  216. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life
  217. Deviation analysis of clinical studies as tool to tune and assess performance of diabetes control algorithms
  218. SPECTRUM
  219. Boluses in Insulin Therapy
  220. Interferences and Limitations in Blood Glucose Self-Testing
  221. Comment on “The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System” by Bailey et al.
  222. Performance of two updated blood glucose monitoring systems: an evaluation following ISO 15197:2013
  223. Continuous Glucose Monitoring in 2015
  224. Self-Monitoring of Blood Glucose
  225. Identification of CGM Time Delays and Implications for BG Control in T1DM
  226. Positionspapier der Kommission für Labordiagnostik in der Diabetologie der DGKL und der DDG
  227. Can We Use Measurements to Classify Patients Suffering from Type 1 Diabetes into Subcategories and Does It Make Sense?
  228. Accuracy of BG Meters and CGM Systems: Possible Influence Factors for the Glucose Prediction Based on Tissue Glucose Concentrations
  229. The Rectangle Target Plot
  230. Accuracy Evaluation of an Integrated Blood Glucose Monitoring System With Improved Test Cassettes Following ISO 15197:2013
  231. Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing(POCT)-Blutglukose-Messsystemen mit Unit-use-Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestati...
  232. Updated Requirements for Measurement Quality and Quality Assurance of Point-Of-Care Testing (POCT) – Blood Glucose Measurement Systems with Unit-Use Reagents Suitable for the Initial Diagnosis of Diabetes Manifested in Pregnancy or Gestational Diabetes...
  233. CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring
  234. Performance Comparison of CGM Systems
  235. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in Unaltered Blood Samples in the Low Glycemic Range and Blood Samples in the Concentration Range Defined by ISO 15197
  236. System Accuracy Evaluation of Different Blood Glucose Monitoring Systems Following ISO 15197:2013 by Using Two Different Comparison Methods
  237. Time Delay of CGM Sensors
  238. Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a Clinical Point of View
  239. Identification of diurnal patterns in insulin action from measured CGM data for patients with T1DM
  240. Diagnostik des Gestationsdiabetes: Die Crux liegt bei der Blutentnahme
  241. ISO 15197:2013 Accuracy Evaluation of Two CE-Marked Systems for Self-Monitoring of Blood Glucose
  242. Neue Technologien in der Diabetologie
  243. System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method
  244. Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy
  245. Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings
  246. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)
  247. Quality of HbA1c Measurement in the Practice
  248. Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing (POCT)-Blutglukose-Messsystemen mit Unit-use Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestat...
  249. Performance assessment of estimation methods for CIR/ISF in bolus calculators∗∗This work has been supported by the Linz Center of Mechatronics (LCM) in the framework of the Austrian COMET-K2 program
  250. LMI-based online estimation of a time-varying time-delay in continuous glucose measurement devices
  251. Use of Microdialysis-Based Continuous Glucose Monitoring to Drive Real-Time Semi-Closed-Loop Insulin Infusion
  252. Self-Monitoring of Blood Glucose
  253. Accuracy Assessment of an Advanced Blood Glucose Monitoring System for Self-Testing With Three Reagent System Lots Following ISO 15197:2013
  254. Model of the glucose-insulin system of type-1 diabetics and optimization-based bolus calculation
  255. Short-term prediction of blood glucose concentration using interval probabilistic models
  256. Accuracy Assessment of Two Novel Systems for Self-Monitoring of Blood Glucose Following ISO 15197:2013
  257. Accuracy Evaluation of Three Systems for Self-monitoring of Blood Glucose With Three Different Test Strip Lots Following ISO 15197
  258. Impact of Partial Pressure of Oxygen in Blood Samples on the Performance of Systems for Self-Monitoring of Blood Glucose
  259. Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility
  260. A-/B-Blutzuckermesssysteme
  261. Konsequenzen der Genauigkeit von Blutglucosemesssystemen
  262. Diabetestechnologie
  263. Auf dem Weg zum „Closed-loop“-System
  264. System accuracy evaluation of systems for point-of-care testing of blood glucose: a comparison of a patient-use system with six professional-use systems
  265. Influence of Partial Pressure of Oxygen in Blood Samples on Measurement Performance in Glucose-Oxidase-Based Systems for Self-Monitoring of Blood Glucose
  266. Partial Pressure of Oxygen in Capillary Blood Samples from the Fingertip
  267. In Response to Teodorczyk and Coauthors: System Accuracy of Blood Glucose Monitoring Devices According to the Current and Proposed ISO 15197 Standards
  268. Assessing the Analytical Performance of Systems for Self-Monitoring of Blood Glucose: Concepts of Performance Evaluation and Definition of Metrological Key Terms
  269. System Accuracy of Blood Glucose Monitoring Systems: Impact of Use by Patients and Ambient Conditions
  270. Performance Evaluation of a Continuous Glucose Monitoring System under Conditions Similar to Daily Life
  271. Evaluation of the Performance of a Novel System for Continuous Glucose Monitoring
  272. Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel
  273. Effect of Infusion Rate and Indwelling Time on Tissue Resistance Pressure in Small-Volume Subcutaneous Infusion like in Continuous Subcutaneous Insulin Infusion
  274. Considerations for an Institution for Evaluation of Diabetes Technology Devices to Improve Their Quality in the European Union
  275. Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use
  276. System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197
  277. Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self-Monitoring of Blood Glucose according to ISO 15197
  278. Increasing Local Blood Flow by Warming the Application Site: Beneficial Effects on Postprandial Glycemic Excursions
  279. Feasibility of Overnight Closed-Loop Control Based on Hourly Blood Glucose Measurements
  280. Integrated Self-Monitoring of Blood Glucose System: Handling Step Analysis
  281. Accuracy in Blood Glucose Measurement: What Will a Tightening of Requirements Yield?
  282. Clinical Performance of a Device That Applies Local Heat to the Insulin Infusion Site: A Crossover Study
  283. Blutzuckermessgeräte
  284. Clinical Performance of Three Bolus Calculators in Subjects with Type 1 Diabetes Mellitus: A Head-to-Head-to-Head Comparison
  285. System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
  286. Experimentelle Untersuchungen und klinische Evidenz der Insulinpumpentherapie (CSII)
  287. Glucose monitoring by microdialysis: performance in a multicentre study
  288. The Clinical Research Tool: A High-Performance Microdialysis-Based System for Reliably Measuring Interstitial Fluid Glucose Concentration
  289. The Circadian Study:: The Get-Up Phenomenon in Type 1 Diabetes
  290. Continuous Glucose Profiles in Healthy Subjects under Everyday Life Conditions and after Different Meals
  291. Recent advances in continuous glucose monitoring